US News

Pfizer, Moderna seen reaping billions from COVID-19 vaccine booster market

Published by

By Michael Erman NEW YORK (Reuters) -Drugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID-19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for years to come, analysts and healthcare investors say. For several months, the companies have said they expect that fully inoculated people will need an extra dose of their vaccines to maintain protection over time and to fend off new coronavirus variants. Now a growing list of governments, including Chile, Germany and Israel, have decided to offer booster doses t…

Read More

Facebook Comments

Check Also

Spanish royal couple visits victims of La Palma volcano eruption

Published by DPA Spain’s King Felipe VI and ...